Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease. These genes could potentially be used as biomarkers ...
Nov 15, 2022
0
63
A Rutgers study of obese adults, all with nonalcoholic fatty liver disease (NAFLD) and morbid obesity (body mass index > 40), has shown that those who underwent bariatric surgery suffered far fewer extreme cardiovascular ...
Nov 14, 2022
0
61
Cardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Diabetes Institute has found that exercise training three to four times per week protects against ...
Nov 8, 2022
0
21
Researchers from the RTI-University of North Carolina (UNC) Evidence-based Practice Center, Research Triangle Park, NC developed a 3-step process to help health care systems identify high-need, high-cost (HNHC) patients. ...
Nov 8, 2022
0
2
Lipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological therapies to decrease its concentration in the bloodstream. Olpasiran is an investigational ...
Nov 7, 2022
1
31
A new study by researchers at Intermountain Healthcare in Salt Lake City finds that following up a cardiac event, such as a heart attack, with a statin prescription and cholesterol measuring blood test, prevents 94% of patients ...
Nov 7, 2022
0
4
A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients without standard modifiable heart risk factors who experience a heart attack are common and more likely to fare better than heart-attack ...
Nov 7, 2022
0
3
For some individuals with advanced kidney disease, dialysis may not be the optimal treatment strategy for their condition, and these patients may be better served with conservative non-dialytic management that focuses on ...
Nov 7, 2022
0
30
Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots.
Nov 1, 2022
0
14
Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review ...
Oct 12, 2022
0
15
